JP2016536357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536357A5 JP2016536357A5 JP2016550931A JP2016550931A JP2016536357A5 JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5 JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- pancreatitis
- dimer
- domain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000539 dimer Substances 0.000 claims 12
- 206010033645 Pancreatitis Diseases 0.000 claims 10
- 239000000178 monomer Substances 0.000 claims 3
- 239000004382 Amylase Substances 0.000 claims 2
- 102000013142 Amylases Human genes 0.000 claims 2
- 108010065511 Amylases Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 235000019418 amylase Nutrition 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108010074051 C-Reactive Protein Proteins 0.000 claims 1
- 102100032752 C-reactive protein Human genes 0.000 claims 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 102000004882 Lipase Human genes 0.000 claims 1
- 108090001060 Lipase Proteins 0.000 claims 1
- 239000004367 Lipase Substances 0.000 claims 1
- 206010033647 Pancreatitis acute Diseases 0.000 claims 1
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 1
- 206010033654 Pancreatitis necrotising Diseases 0.000 claims 1
- 201000003229 acute pancreatitis Diseases 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 208000006766 bile reflux Diseases 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 150000001945 cysteines Chemical class 0.000 claims 1
- 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 claims 1
- 235000019421 lipase Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310549648.XA CN104623639A (zh) | 2013-11-07 | 2013-11-07 | 白介素22二聚体在制备治疗胰腺炎药物中的应用 |
| CN201310549648.X | 2013-11-07 | ||
| PCT/CN2014/090519 WO2015067198A1 (en) | 2013-11-07 | 2014-11-06 | Use of il-22 dimers in manufacture of medicaments for treating pancreatitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019129934A Division JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536357A JP2016536357A (ja) | 2016-11-24 |
| JP2016536357A5 true JP2016536357A5 (OSRAM) | 2017-12-14 |
| JP6825181B2 JP6825181B2 (ja) | 2021-02-03 |
Family
ID=53040916
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550931A Active JP6825181B2 (ja) | 2013-11-07 | 2014-11-06 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
| JP2019129934A Pending JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019129934A Pending JP2019206548A (ja) | 2013-11-07 | 2019-07-12 | 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160271221A1 (OSRAM) |
| EP (1) | EP3065765B1 (OSRAM) |
| JP (2) | JP6825181B2 (OSRAM) |
| CN (2) | CN104623639A (OSRAM) |
| AU (1) | AU2014346051B2 (OSRAM) |
| CA (1) | CA2929637C (OSRAM) |
| ES (1) | ES2794082T3 (OSRAM) |
| WO (1) | WO2015067198A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| CN106146668A (zh) * | 2015-04-01 | 2016-11-23 | 中国人民解放军第二军医大学 | 长效白细胞介素22的制备方法及其用途 |
| US10851133B2 (en) * | 2015-06-08 | 2020-12-01 | New York University | Stabilized minimal coiled-coil mimetics |
| WO2017009469A1 (en) * | 2015-07-16 | 2017-01-19 | Philogen S.P.A. | Il22 immunoconjugates |
| EP3442562B1 (en) | 2016-04-15 | 2022-09-21 | Evive Biotechnology (Shanghai) Ltd | An il-22 dimer for use in treating necrotizing enterocolitis |
| WO2020055768A1 (en) | 2018-09-10 | 2020-03-19 | Cold Spring Harbor Laboratory | Methods for treating pancreatitis |
| CN110302363B (zh) * | 2019-07-04 | 2020-10-09 | 北京大学第三医院（北京大学第三临床医学院） | Il-22作为制备治疗pcos药物的应用及药物制剂 |
| EP4106794A4 (en) * | 2020-02-19 | 2024-03-20 | Evive Biotechnology (Shanghai) Ltd | METHOD FOR TREATING TRANSPLANT AND HOST DISEASE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1013270A3 (en) | 1992-12-02 | 2001-03-28 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
| DE69519382T3 (de) | 1994-09-09 | 2008-09-18 | Takeda Pharmaceutical Co. Ltd. | Zubereitung mit verzögerter freigabe eines metallsalz eines peptids |
| RU2161502C2 (ru) | 1995-06-07 | 2001-01-10 | Элкермес Контролд Терапьютикс, Инк. | Композиция для пролонгированного высвобождения гормона роста человека |
| ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US6274710B1 (en) | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
| US7597876B2 (en) * | 2007-01-11 | 2009-10-06 | Immunomedics, Inc. | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
| CN100515491C (zh) * | 2005-01-04 | 2009-07-22 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| CN102380091A (zh) * | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗病毒性肝炎中的应用 |
| US8690554B2 (en) * | 2011-07-15 | 2014-04-08 | Xylem Ip Holdings Llc | Diaphragm pump using duckbill and other types of valves |
| RS57393B1 (sr) * | 2013-03-15 | 2018-09-28 | Hoffmann La Roche | Il-22 polipeptiidi i il-22 fuzioni proteini i metode za njihovu upotrebu |
-
2013
- 2013-11-07 CN CN201310549648.XA patent/CN104623639A/zh active Pending
-
2014
- 2014-11-06 EP EP14860161.0A patent/EP3065765B1/en active Active
- 2014-11-06 CN CN201480061188.9A patent/CN105705160B/zh active Active
- 2014-11-06 US US15/034,857 patent/US20160271221A1/en not_active Abandoned
- 2014-11-06 ES ES14860161T patent/ES2794082T3/es active Active
- 2014-11-06 CA CA2929637A patent/CA2929637C/en active Active
- 2014-11-06 JP JP2016550931A patent/JP6825181B2/ja active Active
- 2014-11-06 AU AU2014346051A patent/AU2014346051B2/en active Active
- 2014-11-06 WO PCT/CN2014/090519 patent/WO2015067198A1/en not_active Ceased
-
2019
- 2019-07-12 JP JP2019129934A patent/JP2019206548A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536357A5 (OSRAM) | ||
| JP2014530253A5 (OSRAM) | ||
| JP2016532690A5 (OSRAM) | ||
| JP2017528419A5 (OSRAM) | ||
| NZ598348A (en) | Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels | |
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| RU2014150224A (ru) | Сконструированный белок с анкириновым повтором, связывающийся с фактором роста тромбоцитов | |
| TW201613958A (en) | MIC-1 fusion proteins and uses thereof | |
| JP2015522576A5 (OSRAM) | ||
| PE20190920A1 (es) | Anticuerpos modificados de union a fcrn humano y metodos de utilizacion | |
| EA201201047A1 (ru) | Способы и композиции, в которых применяют слитые полипептиды fgf 23 | |
| AR102595A1 (es) | Anticuerpos anti-ang2 y métodos de utilización | |
| PH12014501083A1 (en) | Anticancer fusion protein | |
| WO2016057529A3 (en) | Biphasic single-chain insulin analogues | |
| JP2017531613A5 (OSRAM) | ||
| JP2018538356A5 (OSRAM) | ||
| JP2020507623A5 (OSRAM) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| JP2014526881A5 (OSRAM) | ||
| PL393578A1 (pl) | Przeciwnowotworowe białko fuzyjne | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| FI3065763T4 (fi) | Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten | |
| MX2021012047A (es) | Polipeptidos de fusion de serpina y metodos para utilizar los mismos. | |
| WO2016115511A3 (en) | Vegf variant polypeptide compositions | |
| JP2017505772A5 (OSRAM) |